Live
- CM Kejriwal eating mangoes to raise sugar level to seek bail: ED alleges in Delhi court
- Hindus living in fear under Congress regime, claims K'taka BJP leader
- Apple Releases iOS 17.5 Beta Update with New Features and Enhancements
- Bellamkonda Sai Sreenivas embarks on new thriller project
- Meg Lanning reveals exercise obsession, not eating enough food led to international cricket retirement
- Bajaj Auto's net profit rises to Rs 2,011 crore in Q4, declares dividend of Rs 80 per share
- Even if you don't vote for your son, give him blessings: Rajnath Singh tells A.K. Antony
- Hello Baby song launch event was held by Music Director Koti
- Lyrical marvel ‘Lachhimakka’sets stage for Virinchi Varma’s ‘Jithender Reddy’
- Vikata Sankashti Chaturthi: Date, Time and Ritual
Indian-origin scientist names 4 drugs for corona
An Indian-origin researcher in the US and his team have identified four antiviral drugs -- including remdesivir that was originally developed to treat Ebola -- which may be effective in inhibiting the replication of the novel coronavirus that causes COVID-19
Washington : An Indian-origin researcher in the US and his team have identified four antiviral drugs -- including remdesivir that was originally developed to treat Ebola -- which may be effective in inhibiting the replication of the novel coronavirus that causes COVID-19.
Kamlendra Singh, an associate professor at the University of Missouri in the US, and his colleagues used computer-aided drug design to examine the effectiveness of remdesivir, 5-fluorouracil, ribavirin and favipiravir in treating COVID-19.
The study, published in the journal Pathogens, found that all four drugs were effective in inhibiting, or blocking, the coronavirus' RNA proteins from making genomic copies of the novel coronavirus.
"As researchers, we have an obligation to search for possible treatments given that so many people are dying from this virus," Singh said.
"These antiviral drugs, if they turn out to be effective, all have some limitations.
But in the midst of a global pandemic, they are worth taking a deeper look at because based on our research, we have reason to believe that all of these drugs could potentially be effective in treating COVID-19," he said.
"As researchers, we are simply playing our part in the fight against the pandemic," he said.
